Alan John Camm

1.1k total citations
15 papers, 670 citations indexed

About

Alan John Camm is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, Alan John Camm has authored 15 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 5 papers in Internal Medicine and 2 papers in Economics and Econometrics. Recurrent topics in Alan John Camm's work include Atrial Fibrillation Management and Outcomes (14 papers), Cardiac Arrhythmias and Treatments (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Alan John Camm is often cited by papers focused on Atrial Fibrillation Management and Outcomes (14 papers), Cardiac Arrhythmias and Treatments (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Alan John Camm collaborates with scholars based in United Kingdom, United States and Germany. Alan John Camm's co-authors include Sylvia Haas, Jean‐Pierre Bassand, Ajay K. Kakkar, Shinya Goto, David Fitzmaurice, Gloria Kayani, Samuel Z. Goldhaber, LG Mantovani, Frank Cools and Gregory Y.H. Lip and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Alan John Camm

15 papers receiving 660 citations

Peers

Countries citing papers authored by Alan John Camm

Since Specialization

Citations

This map shows the geographic impact of Alan John Camm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan John Camm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan John Camm more than expected).

Fields of papers citing papers by Alan John Camm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan John Camm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan John Camm. The network helps show where Alan John Camm may publish in the future.

Co-authorship network of co-authors of Alan John Camm

This figure shows the co-authorship network connecting the top 25 collaborators of Alan John Camm. A scholar is included among the top collaborators of Alan John Camm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan John Camm. Alan John Camm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF 2023 ·European Heart Journal Open ·Alan John Camm, Jan Steffel, Saverio Virdone, Jean‐Pierre Bassand, Keith A.A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Alexander G. G. Turpie, Freek W.A. Verheugt, Frank Misselwitz, (unknown), Gloria Kayani, Karen S. Pieper, Ajay K. Kakkar, (unknown)	3
2	Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries 2023 ·Clinical Cardiology ·Toon Wei Lim, Alan John Camm, Saverio Virdone, Daniel E. Singer, Jean Pierre Bassand, Gregg C. Fonarow, Keith A.A. Fox, Michael D. Ezekowitz, Bernard J. Gersh, Gloria Kayani, Elaine M. Hylek, Ajay K. Kakkar, Kenneth W. Mahaffey, Karen S. Pieper, Eric D. Peterson, Jonathan P. Piccini, (unknown)	3
3	Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study 2022 ·International Journal of Cardiology ·Kasper Korsholm, Jan Brink Valentin, Dorte Damgaard, Hans‐Christoph Diener, Alan John Camm, Ulf Landmesser, David Hildick‐Smith, Søren Paaske Johnsen, Jens Erik Nielsen‐Kudsk	13
4	Abstract 12420: Orally Inhaled Flecainide for the Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm: Final Results From the Phase 2 Instant Trial 2022 ·Circulation ·Alan John Camm, Harry J.G.M. Crijns, Arif Elvan, Ype S. Tuininga, Erik Badings, Aaf F.M. Kuijper, (unknown), Mark Lee, (unknown), Isabelle C. Van Gelder, Jeremy N. Ruskin, Peter R. Kowey, Christopher Dufton, Jean Maupas, Luiz Belardinelli	1
5	Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation 2021 ·JACC: Cardiovascular Interventions ·Jens Erik Nielsen‐Kudsk, Kasper Korsholm, Dorte Damgaard, Jan Brink Valentin, Hans‐Christoph Diener, Alan John Camm, Søren Paaske Johnsen	75
6	Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry 2021 ·Journal of Thrombosis and Haemostasis ·Frank Cools, (unknown), Alan John Camm, Jean‐Pierre Bassand, Freek W.A. Verheugt, Shu Yang, Anastasios A. Tsiatis, David Fitzmaurice, Samuel Z. Goldhaber, Gloria Kayani, Shinya Goto, Sylvia Haas, Frank Misselwitz, Alexander G.G. Turpie, Keith A.A. Fox, Karen S. Pieper, Ajay K. Kakkar	24
7	Abstract 10986: Use of the “Pill in the Pocket” Approach for Atrial Fibrillation Termination as Determined from the Antiarrhythmic Medication for Atrial Fibrillation (AIM-AF) Study: A Physician Survey on the Prescription of Antiarrhythmic Drugs in the USA and Europe 2021 ·Circulation ·James A. Reiffel, Carina Blomström‐Lundqvist, Giuseppe Boriani, Andreas Goette, Peter R. Kowey, José Luís Merino, Jonathan P. Piccini, Sanjeev Saksena, Alan John Camm	1
8	Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants 2020 ·Journal of the American College of Cardiology ·Alan John Camm, Frank Cools, Saverio Virdone, Jean‐Pierre Bassand, David Fitzmaurice, (unknown), Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, LG Mantovani, Gloria Kayani, (unknown), (unknown), Ajay K. Kakkar	94
9	The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation 2020 ·Thrombosis and Haemostasis ·Tatjana Potpara, Gregory Y.H. Lip, Carina Blomström‐Lundqvist, Giuseppe Boriani, Isabelle C. Van Gelder, Hein Heidbüchel, Gerhard Hindricks, Alan John Camm	109
10	New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF 2019 ·European Heart Journal - Cardiovascular Pharmacotherapy ·(unknown), Shinya Goto, Karen S. Pieper, Jean‐Pierre Bassand, Alan John Camm, David Fitzmaurice, Samuel Z. Goldhaber, Sylvia Haas, Alexander Parkhomenko, Ali̇ Oto, Frank Misselwitz, Alexander G.G. Turpie, Freek W.A. Verheugt, Keith A.A. Fox, Bernard J. Gersh, Ajay K. Kakkar	33
11	Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF 2016 ·European Heart Journal ·Jean‐Pierre Bassand, Gabriele Accetta, Alan John Camm, Frank Cools, David Fitzmaurice, Keith A.A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, LG Mantovani, Frank Misselwitz, Hugo Ten Cate, Alexander G.G. Turpie, Freek W.A. Verheugt, Ajay K. Kakkar	196
12	Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial 2016 ·EP Europace ·Demosthenes G. Katritsis, Theodoros Zografos, George Katritsis, Eleftherios Giazitzoglou, (unknown), George Paxinos, Alan John Camm, Mark E. Josephson	35
13	Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? 2015 ·Circulation Cardiovascular Quality and Outcomes ·Gregory Y.H. Lip, S. K. Rushton-Smith, Samuel Z. Goldhaber, David Fitzmaurice, LG Mantovani, Shinya Goto, Sylvia Haas, Jean‐Pierre Bassand, Alan John Camm, Giuseppe Ambrosio, Petr Janský, Wael Al Mahmeed, Seil Oh, Martin van Eickels, Pekka Raatikainen, Jan Steffel, Ali̇ Oto, Gloria Kayani, Gabriele Accetta, Ajay K. Kakkar	62
14	Novel anticoagulants and antiplatelet agents; a guide for the urologist 2015 ·British Journal of Urology ·Gidon Ellis, Alan John Camm, Soumendra Nath Datta	15
15	A Nonparametric Approach to QT Interval Correction for Heart Rate 2010 ·Journal of Biopharmaceutical Statistics ·Duolao Wang, Yin Bun Cheung, (unknown), Jörg Täubel, Alan John Camm	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact